Price T Rowe Associates Inc Argenx Se Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Argenx Se stock. As of the latest transaction made, Price T Rowe Associates Inc holds 5,820,547 shares of ARGX stock, worth $3.28 Billion. This represents 0.36% of its overall portfolio holdings.

Number of Shares
5,820,547
Previous 5,598,563 3.97%
Holding current value
$3.28 Billion
Previous $2.41 Billion 31.05%
% of portfolio
0.36%
Previous 0.29%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$434.22 - $551.9 $96.4 Million - $123 Million
221,984 Added 3.97%
5,820,547 $3.16 Billion
Q2 2024

Aug 14, 2024
BUY
$356.01 - $451.55 $33.5 Million - $42.5 Million
94,057 Added 1.71%
5,598,563 $2.41 Billion
Q1 2024

May 15, 2024
BUY
$356.95 - $413.29 $653 Million - $757 Million
1,830,651 Added 49.83%
5,504,506 $2.17 Billion
Q4 2023

Feb 14, 2024
BUY
$338.91 - $506.01 $4.86 Million - $7.26 Million
14,340 Added 0.39%
3,673,855 $1.4 Billion
Q3 2023

Nov 14, 2023
SELL
$369.35 - $548.43 $87.9 Million - $130 Million
-237,904 Reduced 6.1%
3,659,515 $1.8 Billion
Q2 2023

Aug 14, 2023
BUY
$360.14 - $422.58 $26.4 Million - $31 Million
73,436 Added 1.92%
3,897,419 $1.52 Billion
Q1 2023

May 15, 2023
SELL
$334.23 - $403.65 $45.4 Million - $54.8 Million
-135,703 Reduced 3.43%
3,823,983 $1.42 Billion
Q4 2022

Feb 14, 2023
SELL
$342.17 - $402.31 $95.5 Million - $112 Million
-279,003 Reduced 6.58%
3,959,686 $1.5 Billion
Q3 2022

Nov 14, 2022
SELL
$343.2 - $395.75 $734 Million - $846 Million
-2,138,627 Reduced 33.53%
4,238,689 $1.5 Billion
Q2 2022

Aug 15, 2022
BUY
$269.58 - $378.88 $49.3 Million - $69.3 Million
182,835 Added 2.95%
6,377,316 $2.42 Billion
Q1 2022

May 16, 2022
BUY
$254.45 - $351.06 $150 Million - $207 Million
590,925 Added 10.55%
6,194,481 $1.95 Billion
Q4 2021

Feb 14, 2022
BUY
$272.01 - $353.03 $9.88 Million - $12.8 Million
36,318 Added 0.65%
5,603,556 $1.96 Billion
Q3 2021

Nov 15, 2021
SELL
$295.0 - $350.58 $5.7 Million - $6.77 Million
-19,311 Reduced 0.35%
5,567,238 $1.68 Billion
Q2 2021

Aug 16, 2021
SELL
$257.11 - $319.92 $53.2 Million - $66.2 Million
-206,939 Reduced 3.57%
5,586,549 $1.68 Billion
Q1 2021

May 17, 2021
BUY
$268.3 - $380.31 $234 Million - $331 Million
871,508 Added 17.71%
5,793,488 $1.6 Billion
Q4 2020

Feb 16, 2021
BUY
$248.13 - $308.36 $1.22 Billion - $1.52 Billion
4,921,980 New
4,921,980 $1.45 Billion

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email